Join leading researchers and industry experts on 6 May at AstraZeneca Gothenburg for a focused, one-day workshop on the toughest problems in GPCR drug discovery.

GPCRs are central to many therapies but remain underexploited—only ~25% of druggable GPCRs have been targeted. This workshop brings together experts from academia, biotech, and pharma to tackle shared challenges and explore new strategies.

Confirmed speakers include

David E. Gloriam, Copenhagen University

Ekaterina Ratkova, AstraZeneca

Bruno Tillier, Synthelis Biotech

Pawel Kozielewicz, Karolinska Institutet

Julia Kinsolving, Karolinska Institutet

Michael Hennig, LeadXpro

Trevor Wilkinson, AstraZeneca

Organised by AstraZeneca, Uppsala University, Gothenburg University, and InSingulo.

Date: 6 May 2025
Location: AstraZeneca, Gothenburg
Register: insingulo.com/registration